electroCore 2025 Q3 Earnings Beats Revenue Estimates Despite Widening Losses

electroCore (ECOR) reported Q3 2025 earnings with revenue of $8.69 million, . , reflecting strong performance in prescription and wellness segments. However, , .

Revenue

Driven by prescription and wellness product demand, . , supported by gammaCore and Quell sales, . , .

Earnings/Net Income

, . , . Despite strategic investments in sales and marketing, the loss reflects ongoing financial challenges.

Post-Earnings Price Action Review

Following the earnings release, , , . Analysts noted mixed earnings estimate revisions, leading to a Zacks Rank #3 (Hold). While the revenue beat offered optimism, the widening losses and cash burn concerns tempered investor sentiment.

CEO Commentary

. . , .

Guidance

, aligning with Q3 performance and Q4 expectations. Strategic investments in VA expansion, Truvaga, and cost discipline remain priorities. .

Additional News

, board restructuring with Dr. , . .